NasdaqCM - Nasdaq Real Time Price USD

Allarity Therapeutics, Inc. (ALLR)

0.5010 -0.0539 (-9.71%)
At close: June 7 at 4:00 PM EDT
0.5249 +0.02 (+4.77%)
Pre-Market: 5:45 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Expense
17,701.0000
17,129.0000
16,892.0000
26,556.0000
8,319.0000
--
Operating Income
-17,701.0000
-17,129.0000
-16,892.0000
-26,556.0000
-8,319.0000
--
Net Non Operating Interest Income Expense
-490.0000
-476.0000
-193.0000
-1,987.0000
-320.0000
--
Other Income Expense
5,878.0000
5,787.0000
-494.0000
2,028.0000
2,220.0000
--
Pretax Income
-12,313.0000
-11,818.0000
-17,579.0000
-26,515.0000
-6,419.0000
--
Tax Provision
79.0000
83.0000
-1,521.0000
133.0000
198.0000
--
Net Income Common Stockholders
-20,940.0000
-20,416.0000
-21,051.0000
-26,648.0000
-6,602.0000
--
Diluted NI Available to Com Stockholders
-20,940.0000
-20,416.0000
-21,051.0000
-26,648.0000
-6,602.0000
--
Basic EPS
1.61k
-205.20
-1.06k
-3.35k
-1.17k
--
Diluted EPS
1.61k
-205.20
-1.06k
-3.35k
-1.17k
--
Basic Average Shares
471.1740
99.5370
19.8720
7.9480
5.6660
--
Diluted Average Shares
471.1740
99.5370
19.8720
7.9480
5.6660
--
Total Operating Income as Reported
-17,701.0000
-17,129.0000
-34,463.0000
-26,556.0000
-8,319.0000
--
Total Expenses
17,701.0000
17,129.0000
16,892.0000
26,556.0000
8,319.0000
--
Net Income from Continuing & Discontinued Operation
-12,392.0000
-11,901.0000
-16,058.0000
-26,648.0000
-6,602.0000
--
Normalized Income
-16,273.4000
-16,939.6200
-15,606.7427
-28,474.4600
-8,640.8900
--
Interest Income
18.0000
22.0000
30.0000
--
--
--
Interest Expense
508.0000
498.0000
223.0000
640.0000
320.0000
--
Net Interest Income
-490.0000
-476.0000
-193.0000
-1,987.0000
-320.0000
--
EBIT
-11,805.0000
-11,320.0000
-17,356.0000
-25,875.0000
-6,099.0000
--
EBITDA
-11,776.0000
-11,283.0000
-17,296.0000
-25,769.0000
-6,053.0000
--
Reconciled Depreciation
29.0000
37.0000
60.0000
106.0000
46.0000
--
Net Income from Continuing Operation Net Minority Interest
-12,392.0000
-11,901.0000
-16,058.0000
-26,648.0000
-6,602.0000
--
Total Unusual Items Excluding Goodwill
6,469.0000
6,378.0000
-494.0000
2,502.0000
2,793.0000
--
Total Unusual Items
6,469.0000
6,378.0000
-494.0000
2,502.0000
2,793.0000
--
Normalized EBITDA
-18,245.0000
-17,661.0000
-16,802.0000
-28,271.0000
-8,846.0000
--
Tax Rate for Calcs
0.0004
0.0002
0.0001
0.0003
0.0003
--
Tax Effect of Unusual Items
2,587.6000
1,339.3800
-42.7427
675.5400
754.1100
--
12/31/2019 - 12/21/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KTRA Kintara Therapeutics, Inc.
0.2103
-18.11%
 
SCPX Scorpius Holdings, Inc.
0.1083
-9.75%
 
TCBP TC Biopharm (Holdings) Plc
1.0800
-7.69%
 
BDRX Biodexa Pharmaceuticals Plc
0.9391
-5.94%
 
VIRI Virios Therapeutics, Inc.
0.2280
-3.39%
 
VRAX Virax Biolabs Group Limited
1.9700
0.00%
 
CYCC Cyclacel Pharmaceuticals, Inc.
2.0000
+1.01%
 
MBIO Mustang Bio, Inc.
0.1485
-4.19%
 
INM InMed Pharmaceuticals Inc.
0.2354
-7.69%
 
ICU SeaStar Medical Holding Corporation
5.49
+2,457.11%